Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization (EUA) to include a booster...
Pfizer's $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as cash-flush...
Pfizer stock fell 0.9% in premarket trading on Tuesday after the pharma giant said Paxlovid, its antiviral drug for treating COVID-19, will generate less...
Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...
Strides Pharma Science Ltd., a global pharmaceutical company, today announced a sub-license agreement with MPP to commercialize a generic version of Pfizer’s COVID-19 oral...
Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets.
The company...